UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 180

Sortiert nach

Single-cell microRNA sequencing method comparison and application to cell lines and circulating lung tumor cells

Nature communications, 2021-07, Vol.12 (1), p.4316-4316, Article 4316

2021

Volltextzugriff (PDF)

Editorial: Integrating transcriptional modulation in systemic tumor therapy

Frontiers in oncology, 2024, Vol.14, p.1385766-1385766

2024

Volltextzugriff (PDF)

Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance

Cancers, 2023-12, Vol.16 (1), p.180

2023

Volltextzugriff (PDF)

The metastatic infiltration at the metastasis/brain parenchyma-interface is very heterogeneous and has a significant impact on survival in a prospective study

Oncotarget, 2015-10, Vol.6 (30), p.29254-29267

2015

Volltextzugriff (PDF)

Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue

International journal of molecular sciences, 2018-11, Vol.19 (11), p.3540

2018

Volltextzugriff (PDF)

Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity

Frontiers in oncology, 2024-01, Vol.13, p.1289222-1289222

2024

Volltextzugriff (PDF)

Drug Repurposing by Tumor Tissue Editing

Frontiers in oncology, 2022-06, Vol.12, p.900985-900985

2022

Volltextzugriff (PDF)

Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis

Frontiers in pharmacology, 2018-11, Vol.9, p.1357

2018

Volltextzugriff (PDF)

Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature

Frontiers in oncology, 2022-05, Vol.12, p.886436

2022

Volltextzugriff (PDF)

All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma

Frontiers in oncology, 2023-05, Vol.13, p.1177330-1177330

2023

Volltextzugriff (PDF)

Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy

Frontiers in pharmacology, 2021-06, Vol.12, p.599552-599552

2021

Volltextzugriff (PDF)

Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease

Frontiers in pharmacology, 2021-06, Vol.12, p.599561-599561

2021

Volltextzugriff (PDF)

Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue-Going Beyond Apoptosis Induction

Frontiers in oncology, 2019-12, Vol.9, p.1408

2019

Volltextzugriff (PDF)

Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy

Current oncology (Toronto), 2021-03, Vol.28 (2), p.1161-1169

2021

Volltextzugriff (PDF)

Coronavirus disease 2019 induces multi‐lineage, morphologic changes in peripheral blood cells

EJHaem, 2020-07, Vol.1 (1), p.376-383

2020

Volltextzugriff (PDF)

On the function of chitin synthase extracellular domains in biomineralization

Journal of structural biology, 2013-08, Vol.183 (2), p.216-225

2013

Volltextzugriff (PDF)

Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities

Journal of personalized medicine, 2022-08, Vol.12 (8), p.1270

2022

Volltextzugriff (PDF)

Einfluss des PPARγ Agonisten Pioglitazon auf murine Knochenmarksmakrophagen im Kontext des Mammakarzinoms

Lüke, Florian

2019

Volltextzugriff (PDF)

Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone

The Journal of clinical investigation, 2021-11, Vol.131 (22), p.1-16

2021

Volltextzugriff (PDF)

“Uninformed consent” in clinical trials with cancer patients: A qualitative analysis of patients’ and support persons’ communication experiences and needs

Patient education and counseling, 2024-05, Vol.122, p.108144-108144, Article 108144

2024

Volltextzugriff (PDF)

1 – 25 von 180

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(159)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(177)
Japanisch
(15)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(117)
Life Sciences & Biomedicine
(74)
Humans
(38)
Physical Sciences
(33)
Female
(19)
Animals
(18)
Chemistry
(15)
Male
(15)
Oncology
(15)
Science & Technology - Other Topics
(14)
Technology
(13)
Environmental Sciences & Ecology
(12)
Life Sciences
(12)
Anakoinosis
(11)
Analysis
(11)
Environmental Sciences
(11)
Gene Expression
(11)
Physics
(11)
Adult
(10)
Tumors
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Single-cell microRNA sequencing method comparison and application to cell lines and circulating lung tumor cells

Editorial: Integrating transcriptional modulation in systemic tumor therapy

Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance

The metastatic infiltration at the metastasis/brain parenchyma-interface is very heterogeneous and has a significant impact on survival in a prospective study

Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue

Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson’s disease: Balancing immunosuppression

Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity

Drug Repurposing by Tumor Tissue Editing

Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis

Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature

All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma

Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy

Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease

Identification of Disparities in Personalized Cancer Care—A Joint Approach of the German WERA Consortium

Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue-Going Beyond Apoptosis Induction

Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy

Coronavirus disease 2019 induces multi‐lineage, morphologic changes in peripheral blood cells

On the function of chitin synthase extracellular domains in biomineralization

A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung)

Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities

Low-dose azacitidine, pioglitazone and all- trans retinoic acid is safe in patients aged ≥60 years with acute myeloid leukemia refractory to standard induction chemotherapy (AMLSG 26-16/AML-ViVA): results of the safety run-in phase

Einfluss des PPARγ Agonisten Pioglitazon auf murine Knochenmarksmakrophagen im Kontext des Mammakarzinoms

Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone

“Uninformed consent” in clinical trials with cancer patients: A qualitative analysis of patients’ and support persons’ communication experiences and needs

CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial

Suchergebnisse filtern